The Role of the dpp4 Inhibitors: A Current Approach in the Management of Diabetes Mellitus type 2

Abstract

Diabetes mellitus type 2 (dm2) is considered one of the illnesses that greater morbidity and mortality will have around the world in the coming years. Currently we have developed new therapeutic lines that allow better oversight of this pathology. This article analyzes dipeptidyl peptidase 4 inhibitors (dpp4) as a focus on the treatment of dm.